Fondren Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Fondren Management’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-25,136	Closed	-$26K	–	110
2019 Q1	$26K	Buy	+25,136	New	+$20.5K	0.02%	82

Fondren Management's OMED Position: Q2 2019 in Review

Fondren Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 25,136 shares — an estimated $26K sold.

Fondren Management first reported a position in OMED in Q1 2019 and held it in 1 quarter. The position peaked at $26K in Q1 2019. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Fondren Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Fondren Management sold 25,136 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $26K.
Fondren Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2019 and held it in 1 quarter.
Fondren Management's OncoMed Pharmaceuticals, Inc. position peaked at $26K in Q1 2019.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Fondren Management's 13F filing for Q2 2019, filed 14 Aug 2019.